Inventor

Christine Rouzioux

Inventor

Paris, FR

Overview

1987–2019

Patent span

Chemistry

Primary field (CPC C)

Patents· 20 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary

C07KPeptides25%

C12NMicroorganisms or enzymes24%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms15%

G01NInvestigating or analysing materials by determining their chemical or physical properties15%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests10%

A61KPreparations for medical, dental or toiletry purposes9%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations1%

PatentTitleYear

10,385,410In vitro method for the detection and quantification of HIV-22019 7,341,731'HIV-2 antigen compositions'2008 7,232,654'DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1)'2007 7,217,508'Cloned DNA sequence related to genomic RNA of human immunodeficiency virus (HIV-1)'2007 7,205,102'Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated virus (LAV) and proteins encoded by said LAV genomic RNA'2007 7,122,188'Antibodies which bind with proteins of human immunodeficiency virus type 1 (HIV-1), and immune complexes comprising proteins of HIV-1'2006 7,115,363'Retrovirus capable of causing AIDS, means and methods for detecting it in vitro'2006 6,664,041'Method for preparing a viral extract containing HIV-II RNA'2003 6,627,395'Methods for the propagation, isolation, identification, and preparation of human immunodeficiency virus type 1 (HIV-1)'2003 6,600,023'Antibody directed against HIV-1 P25 antigen'2003 6,428,952'Methods and kits employing LAV antigens for the detection of HIV-1-specific antibodies'2002 6,395,495'Methods and kits for detecting antibodies against an HIV variant'2002 6,265,149'In vitro diagnostic methods and kits for the detection of HIV-2-specific antibodies'2001 6,037,165'Methods for the preparation of human immunodeficiency virus type 2 (HIV-2) and antigens encoped thereby'2000 5,374,519'Oligopeptides comprising p18 protein of human immunodeficiency virus (HIV), compositions comprising peptides of p18 protein of HIV, and diagnostic kits and methods for detecting acquired immune deficiency syndrome (AIDS)'1994 5,217,861'Antigen of a human retrovirus, namely p18 protein of human immunodeficiency virus (HIV), compositions containing the antigen, a diagnostic method for detecting acquired immune deficiency syndrome (AIDS) and pre-AIDS and a kit therefor'1993 5,173,400'Antibody detection of antibodies to viral proteins in serum'1992 5,135,864'Human Immunodeficiency Virus (HIV) associated with Acquired Immunual Deficiency Syndrome (AIDS), a diagnostic method for aids and pre-aids, and a kit therefor'1992 5,066,782'Retrovirus capable of causing AIDS, means and method for detecting it in vitro'1991 4,708,818'Human immunodeficiency viruses associated with Acquired Immune Deficiency Syndrome (AIDS), a diagnostic method for AIDS and pre-AIDS, and a kit therefor'1987

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1987–2008Patents assigned to PASTEUR INSTITUT (16)· patent assignee history

1987–2007Patents assigned to US HEALTH (9)· patent assignee history

1987–2019Based in Paris, FR· patent location history

2019Patents assigned to Chu de Rouen (1)· patent assignee history

2019Patents assigned to HOPITAUX PARIS ASSIST PUBLIQUE (1)· patent assignee history

2019Patents assigned to INST NAT SANTE RECH MED (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
PASTEUR INSTITUT	16	1987–2008
US HEALTH	9	1987–2007
Chu de Rouen	1	2019
HOPITAUX PARIS ASSIST PUBLIQUE	1	2019
INST NAT SANTE RECH MED	1	2019

Locations

Location	Patents	Span
Paris, FR	20	1987–2019